MX358142B - Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones. - Google Patents

Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones.

Info

Publication number
MX358142B
MX358142B MX2012012324A MX2012012324A MX358142B MX 358142 B MX358142 B MX 358142B MX 2012012324 A MX2012012324 A MX 2012012324A MX 2012012324 A MX2012012324 A MX 2012012324A MX 358142 B MX358142 B MX 358142B
Authority
MX
Mexico
Prior art keywords
treatment
males
formulations
hydroxy
acid derivatives
Prior art date
Application number
MX2012012324A
Other languages
English (en)
Spanish (es)
Other versions
MX2012012324A (es
Inventor
Forbes William
Johnson Lorin
Bortey Enoch
Original Assignee
Salix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44861888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX358142(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salix Pharmaceuticals Ltd filed Critical Salix Pharmaceuticals Ltd
Publication of MX2012012324A publication Critical patent/MX2012012324A/es
Publication of MX358142B publication Critical patent/MX358142B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
MX2012012324A 2010-04-26 2011-04-26 Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones. MX358142B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32815110P 2010-04-26 2010-04-26
PCT/US2011/033905 WO2011137103A1 (en) 2010-04-26 2011-04-26 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Publications (2)

Publication Number Publication Date
MX2012012324A MX2012012324A (es) 2013-01-29
MX358142B true MX358142B (es) 2018-08-06

Family

ID=44861888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012324A MX358142B (es) 2010-04-26 2011-04-26 Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones.

Country Status (9)

Country Link
US (3) US8497256B2 (enExample)
EP (1) EP2563117B1 (enExample)
JP (1) JP2013525440A (enExample)
AU (1) AU2011245455A1 (enExample)
BR (2) BR122014009845A2 (enExample)
CA (1) CA2797560A1 (enExample)
IL (1) IL222642A0 (enExample)
MX (1) MX358142B (enExample)
WO (1) WO2011137103A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021528385A (ja) 2018-06-05 2021-10-21 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド 自己免疫障害を治療するためのアシル化活性剤およびその使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326364A (en) 1885-09-15 Electric-lamp hanger
US4298595A (en) 1978-12-20 1981-11-03 Dynapol Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
EP0439453B1 (en) 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Improved method for treatment of gastrointestinal disorders
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5519014A (en) 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5498608A (en) 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US5905073A (en) 1995-01-06 1999-05-18 Salix Pharmaceuticals, Inc. Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
SE9700934D0 (sv) 1997-03-14 1997-03-14 Astra Ab New formulation
US6551632B2 (en) 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
DE69839261T2 (de) 1997-04-01 2009-03-26 Borody, Thomas Julius, Five Dock Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
AUPO665397A0 (en) 1997-05-07 1997-05-29 Borody, Thomas Julius Novel therapy for constipation
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
EP2529729A1 (en) 2005-08-24 2012-12-05 Salix Pharmaceuticals, Inc. Balsalazide formulations and manufacture thereof
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US20100048519A1 (en) 2006-09-13 2010-02-25 Chyon-Hwa Yeh Methods of treatment for ulcerative colitis using aminosalicylate

Also Published As

Publication number Publication date
BR112012027520A2 (pt) 2015-09-15
EP2563117A1 (en) 2013-03-06
WO2011137103A1 (en) 2011-11-03
US20120058184A1 (en) 2012-03-08
EP2563117A4 (en) 2013-09-04
US20130295178A1 (en) 2013-11-07
IL222642A0 (en) 2012-12-31
JP2013525440A (ja) 2013-06-20
CA2797560A1 (en) 2011-11-03
US8497256B2 (en) 2013-07-30
US20150132381A1 (en) 2015-05-14
EP2563117B1 (en) 2018-02-21
BR122014009845A2 (pt) 2015-12-29
MX2012012324A (es) 2013-01-29
AU2011245455A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
IN2015DN01156A (enExample)
TN2012000465A1 (en) Derivatives of 1-amino-2-cyclopropylethylboronic acid
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
MX2011007930A (es) Conjugados de insulina cristalina.
PH12013500467A1 (en) Pharmaceutical composition
PH12012501680A1 (en) Compositions and methods for the diagnosis and treatment of tumor
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
MX338489B (es) Derivados de hidantoina utiles como inhibidores de kv3.
MX348823B (es) Formulaciones estables de linaclotida.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
PH12015501609A1 (en) Phenicol antibacterials
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
IN2014DN07483A (enExample)
BR112013000776A2 (pt) método e formulação para tratamento de deficiência de ácido siálico
UA109144C2 (ru) Дезинфицирующий и антисептический препарат с пониженным содержанием йода
MX342947B (es) Tratamiento de diabetes tipo 2.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
MX2014004710A (es) Composiciones farmaceuticas que comprenden dgla y/o 15-hetre y metodos para usar los mismos.
PH12012501963A1 (en) Compositions and methods for the diagnosis and treatment of tumor
HK1201067A1 (en) Sialic acid analogs
MX344189B (es) Formulaciones de mazindol.
MX356727B (es) Formulaciones de liberacion modificada de viloxacina.
IN2015DN02109A (enExample)
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles

Legal Events

Date Code Title Description
FG Grant or registration